Viewing Study NCT00004393


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT00004393
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-10-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome
Sponsor: National Center for Research Resources (NCRR)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module